EBITDA growth is remarkable given the circumstances. Corporate + FTTB (and clinical efficiency) is charging forwards.
PH2 Hydrogen in Germany – Who will solve the “chicken and egg problem”? Pure Hydrogen, thyssenkrupp, NEL